Physician profile
Mark Dean
NPI 1902812316
$9,350.09
in general payments reported to CMS, 2019-2025
14 companies · $35.18 in 2025
The $35.18 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,744 · 2020: $1,489 · 2021: $68.63 · 2022: $2,001 · 2023: $423 · 2024: $1,589 · 2025: $35.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,310 · Food and Beverage: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,310.20 |
| Food and Beverage | $737.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,320.04 | 2019-2024 | |
| Exactech, INC. | $1,760.11 | 2022 | |
| Peerless Surgical INC. | $1,737.10 | 2019-2024 | |
| Depuy Synthes Sales INC. | $155.71 | 2022-2023 | Skyline |
| Pacira Therapeutics, INC. | $125.68 | 2019-2021 | |
| Optos, INC. | $76.93 | 2022 | |
| Acclarent, INC | $47.95 | 2021 | |
| Radius Health, INC. | $20.76 | 2024 | |
| Curonix LLC | $20.44 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $18.57 | 2023 | Proclaim |
| Stryker Corporation | $17.94 | 2019 | |
| Bioventus LLC | $17.49 | 2020 | |
| Vericel Corporation | $16.63 | 2019 | |
| Innovation Technologies INC | $14.74 | 2025 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.